nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—schizophrenia—Dimenhydrinate—atopic dermatitis	0.274	0.569	CpDpCtD
Ziprasidone—schizophrenia—Diphenhydramine—atopic dermatitis	0.208	0.431	CpDpCtD
Ziprasidone—CHRM2—Dimenhydrinate—atopic dermatitis	0.0397	0.123	CbGbCtD
Ziprasidone—HRH1—Dimenhydrinate—atopic dermatitis	0.0362	0.113	CbGbCtD
Ziprasidone—KCNH2—Loratadine—atopic dermatitis	0.03	0.0933	CbGbCtD
Ziprasidone—CYP3A7—Tacrolimus—atopic dermatitis	0.021	0.0652	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.021	0.0652	CbGbCtD
Ziprasidone—CHRM2—Diphenhydramine—atopic dermatitis	0.0194	0.0602	CbGbCtD
Ziprasidone—HRH1—Diphenhydramine—atopic dermatitis	0.0177	0.055	CbGbCtD
Ziprasidone—HRH1—Loratadine—atopic dermatitis	0.0177	0.055	CbGbCtD
Ziprasidone—CYP3A5—Tacrolimus—atopic dermatitis	0.0157	0.0489	CbGbCtD
Ziprasidone—CYP3A4—Pimecrolimus—atopic dermatitis	0.0103	0.0321	CbGbCtD
Ziprasidone—CYP1A2—Diphenhydramine—atopic dermatitis	0.00857	0.0266	CbGbCtD
Ziprasidone—CYP3A7—Hydrocortisone—atopic dermatitis	0.00854	0.0266	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.00854	0.0266	CbGbCtD
Ziprasidone—CYP2D6—Loratadine—atopic dermatitis	0.00706	0.022	CbGbCtD
Ziprasidone—CYP2D6—Diphenhydramine—atopic dermatitis	0.00706	0.022	CbGbCtD
Ziprasidone—DRD5—eyelid—atopic dermatitis	0.00679	0.358	CbGeAlD
Ziprasidone—CYP3A5—Hydrocortisone—atopic dermatitis	0.00641	0.0199	CbGbCtD
Ziprasidone—CYP3A4—Tacrolimus—atopic dermatitis	0.00614	0.0191	CbGbCtD
Ziprasidone—CYP3A7—Dexamethasone—atopic dermatitis	0.00531	0.0165	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.00531	0.0165	CbGbCtD
Ziprasidone—CYP3A4—Loratadine—atopic dermatitis	0.00449	0.014	CbGbCtD
Ziprasidone—CYP3A4—Methylprednisolone—atopic dermatitis	0.00411	0.0128	CbGbCtD
Ziprasidone—CYP3A5—Dexamethasone—atopic dermatitis	0.00398	0.0124	CbGbCtD
Ziprasidone—CYP3A4—Triamcinolone—atopic dermatitis	0.00311	0.00968	CbGbCtD
Ziprasidone—CYP3A4—Betamethasone—atopic dermatitis	0.00267	0.0083	CbGbCtD
Ziprasidone—CYP3A4—Prednisolone—atopic dermatitis	0.00263	0.00819	CbGbCtD
Ziprasidone—CYP3A4—Hydrocortisone—atopic dermatitis	0.0025	0.00777	CbGbCtD
Ziprasidone—CYP3A4—Prednisone—atopic dermatitis	0.00249	0.00774	CbGbCtD
Ziprasidone—CYP2D6—Dexamethasone—atopic dermatitis	0.00244	0.0076	CbGbCtD
Ziprasidone—CHRM5—skin epidermis—atopic dermatitis	0.00191	0.101	CbGeAlD
Ziprasidone—CYP3A4—Dexamethasone—atopic dermatitis	0.00155	0.00483	CbGbCtD
Ziprasidone—H1F0—neck—atopic dermatitis	0.000787	0.0415	CbGeAlD
Ziprasidone—CHRM5—skin of body—atopic dermatitis	0.00059	0.0311	CbGeAlD
Ziprasidone—HTR1E—head—atopic dermatitis	0.000562	0.0297	CbGeAlD
Ziprasidone—H1F0—skin of body—atopic dermatitis	0.000509	0.0269	CbGeAlD
Ziprasidone—CHRM4—head—atopic dermatitis	0.000493	0.026	CbGeAlD
Ziprasidone—HTR7—neck—atopic dermatitis	0.000485	0.0256	CbGeAlD
Ziprasidone—DRD3—head—atopic dermatitis	0.000458	0.0242	CbGeAlD
Ziprasidone—HTR6—head—atopic dermatitis	0.000441	0.0233	CbGeAlD
Ziprasidone—DRD5—head—atopic dermatitis	0.000429	0.0227	CbGeAlD
Ziprasidone—CHRM5—head—atopic dermatitis	0.000385	0.0203	CbGeAlD
Ziprasidone—ADRA1B—head—atopic dermatitis	0.000352	0.0186	CbGeAlD
Ziprasidone—H1F0—head—atopic dermatitis	0.000332	0.0175	CbGeAlD
Ziprasidone—DRD1—head—atopic dermatitis	0.000328	0.0173	CbGeAlD
Ziprasidone—HTR3A—head—atopic dermatitis	0.000317	0.0167	CbGeAlD
Ziprasidone—HTR2A—neck—atopic dermatitis	0.000303	0.016	CbGeAlD
Ziprasidone—HTR1B—head—atopic dermatitis	0.000266	0.014	CbGeAlD
Ziprasidone—CHRM2—head—atopic dermatitis	0.000264	0.014	CbGeAlD
Ziprasidone—HTR1D—head—atopic dermatitis	0.000257	0.0136	CbGeAlD
Ziprasidone—HTR2C—head—atopic dermatitis	0.000255	0.0134	CbGeAlD
Ziprasidone—SLC6A4—head—atopic dermatitis	0.000242	0.0127	CbGeAlD
Ziprasidone—CHRM1—head—atopic dermatitis	0.000241	0.0127	CbGeAlD
Ziprasidone—CHRM3—head—atopic dermatitis	0.000215	0.0114	CbGeAlD
Ziprasidone—HTR1A—head—atopic dermatitis	0.000215	0.0113	CbGeAlD
Ziprasidone—HTR7—head—atopic dermatitis	0.000205	0.0108	CbGeAlD
Ziprasidone—ADRA1A—head—atopic dermatitis	0.000198	0.0104	CbGeAlD
Ziprasidone—DRD2—head—atopic dermatitis	0.000194	0.0102	CbGeAlD
Ziprasidone—KCNH2—head—atopic dermatitis	0.000191	0.0101	CbGeAlD
Ziprasidone—ADRA2C—head—atopic dermatitis	0.000188	0.00994	CbGeAlD
Ziprasidone—HRH1—head—atopic dermatitis	0.000153	0.00808	CbGeAlD
Ziprasidone—ADRA2A—head—atopic dermatitis	0.00015	0.00793	CbGeAlD
Ziprasidone—HTR2A—head—atopic dermatitis	0.000128	0.00675	CbGeAlD
Ziprasidone—CYP2D6—head—atopic dermatitis	0.000116	0.00614	CbGeAlD
Ziprasidone—Syncope—Hydrocortisone—atopic dermatitis	4.62e-05	0.000377	CcSEcCtD
Ziprasidone—Diarrhoea—Tacrolimus—atopic dermatitis	4.61e-05	0.000376	CcSEcCtD
Ziprasidone—Angiopathy—Betamethasone—atopic dermatitis	4.59e-05	0.000374	CcSEcCtD
Ziprasidone—Angiopathy—Dexamethasone—atopic dermatitis	4.59e-05	0.000374	CcSEcCtD
Ziprasidone—Hypertension—Prednisolone—atopic dermatitis	4.56e-05	0.000371	CcSEcCtD
Ziprasidone—Loss of consciousness—Hydrocortisone—atopic dermatitis	4.53e-05	0.000369	CcSEcCtD
Ziprasidone—Arrhythmia—Dexamethasone—atopic dermatitis	4.52e-05	0.000368	CcSEcCtD
Ziprasidone—Arrhythmia—Betamethasone—atopic dermatitis	4.52e-05	0.000368	CcSEcCtD
Ziprasidone—Bradycardia—Prednisone—atopic dermatitis	4.49e-05	0.000366	CcSEcCtD
Ziprasidone—Alopecia—Dexamethasone—atopic dermatitis	4.47e-05	0.000364	CcSEcCtD
Ziprasidone—Alopecia—Betamethasone—atopic dermatitis	4.47e-05	0.000364	CcSEcCtD
Ziprasidone—Dizziness—Tacrolimus—atopic dermatitis	4.46e-05	0.000363	CcSEcCtD
Ziprasidone—Hypertension—Hydrocortisone—atopic dermatitis	4.45e-05	0.000363	CcSEcCtD
Ziprasidone—Angioedema—Triamcinolone—atopic dermatitis	4.44e-05	0.000361	CcSEcCtD
Ziprasidone—Haemoglobin—Prednisone—atopic dermatitis	4.43e-05	0.000361	CcSEcCtD
Ziprasidone—Angioedema—Methylprednisolone—atopic dermatitis	4.43e-05	0.000361	CcSEcCtD
Ziprasidone—Haemorrhage—Prednisone—atopic dermatitis	4.41e-05	0.000359	CcSEcCtD
Ziprasidone—Erythema—Betamethasone—atopic dermatitis	4.4e-05	0.000359	CcSEcCtD
Ziprasidone—Erythema—Dexamethasone—atopic dermatitis	4.4e-05	0.000359	CcSEcCtD
Ziprasidone—Myalgia—Hydrocortisone—atopic dermatitis	4.39e-05	0.000358	CcSEcCtD
Ziprasidone—Anxiety—Hydrocortisone—atopic dermatitis	4.37e-05	0.000356	CcSEcCtD
Ziprasidone—Vertigo—Triamcinolone—atopic dermatitis	4.36e-05	0.000355	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	4.36e-05	0.000355	CcSEcCtD
Ziprasidone—Syncope—Triamcinolone—atopic dermatitis	4.35e-05	0.000355	CcSEcCtD
Ziprasidone—Vertigo—Methylprednisolone—atopic dermatitis	4.35e-05	0.000355	CcSEcCtD
Ziprasidone—Syncope—Methylprednisolone—atopic dermatitis	4.34e-05	0.000354	CcSEcCtD
Ziprasidone—Connective tissue disorder—Prednisone—atopic dermatitis	4.33e-05	0.000353	CcSEcCtD
Ziprasidone—Vomiting—Tacrolimus—atopic dermatitis	4.29e-05	0.000349	CcSEcCtD
Ziprasidone—Loss of consciousness—Triamcinolone—atopic dermatitis	4.27e-05	0.000348	CcSEcCtD
Ziprasidone—Loss of consciousness—Methylprednisolone—atopic dermatitis	4.26e-05	0.000347	CcSEcCtD
Ziprasidone—Rash—Tacrolimus—atopic dermatitis	4.25e-05	0.000347	CcSEcCtD
Ziprasidone—Dermatitis—Tacrolimus—atopic dermatitis	4.25e-05	0.000346	CcSEcCtD
Ziprasidone—Shock—Prednisolone—atopic dermatitis	4.24e-05	0.000345	CcSEcCtD
Ziprasidone—Cough—Triamcinolone—atopic dermatitis	4.24e-05	0.000345	CcSEcCtD
Ziprasidone—Headache—Tacrolimus—atopic dermatitis	4.23e-05	0.000344	CcSEcCtD
Ziprasidone—Tachycardia—Prednisolone—atopic dermatitis	4.2e-05	0.000343	CcSEcCtD
Ziprasidone—Hypertension—Triamcinolone—atopic dermatitis	4.19e-05	0.000341	CcSEcCtD
Ziprasidone—Hypertension—Methylprednisolone—atopic dermatitis	4.18e-05	0.000341	CcSEcCtD
Ziprasidone—Infection—Hydrocortisone—atopic dermatitis	4.18e-05	0.000341	CcSEcCtD
Ziprasidone—Hyperhidrosis—Prednisolone—atopic dermatitis	4.16e-05	0.000339	CcSEcCtD
Ziprasidone—Shock—Hydrocortisone—atopic dermatitis	4.14e-05	0.000337	CcSEcCtD
Ziprasidone—Myalgia—Triamcinolone—atopic dermatitis	4.13e-05	0.000337	CcSEcCtD
Ziprasidone—Nervous system disorder—Hydrocortisone—atopic dermatitis	4.13e-05	0.000336	CcSEcCtD
Ziprasidone—Arthralgia—Methylprednisolone—atopic dermatitis	4.12e-05	0.000336	CcSEcCtD
Ziprasidone—Myalgia—Methylprednisolone—atopic dermatitis	4.12e-05	0.000336	CcSEcCtD
Ziprasidone—Eye disorder—Prednisone—atopic dermatitis	4.12e-05	0.000336	CcSEcCtD
Ziprasidone—Anxiety—Methylprednisolone—atopic dermatitis	4.11e-05	0.000335	CcSEcCtD
Ziprasidone—Tachycardia—Hydrocortisone—atopic dermatitis	4.11e-05	0.000335	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	4.1e-05	0.000334	CcSEcCtD
Ziprasidone—Skin disorder—Hydrocortisone—atopic dermatitis	4.09e-05	0.000333	CcSEcCtD
Ziprasidone—Hyperhidrosis—Hydrocortisone—atopic dermatitis	4.07e-05	0.000331	CcSEcCtD
Ziprasidone—Dry mouth—Triamcinolone—atopic dermatitis	4.04e-05	0.000329	CcSEcCtD
Ziprasidone—Angioedema—Dexamethasone—atopic dermatitis	4.02e-05	0.000328	CcSEcCtD
Ziprasidone—Angioedema—Betamethasone—atopic dermatitis	4.02e-05	0.000328	CcSEcCtD
Ziprasidone—Anorexia—Hydrocortisone—atopic dermatitis	4.01e-05	0.000327	CcSEcCtD
Ziprasidone—Nausea—Tacrolimus—atopic dermatitis	4.01e-05	0.000326	CcSEcCtD
Ziprasidone—Angiopathy—Prednisone—atopic dermatitis	4e-05	0.000326	CcSEcCtD
Ziprasidone—Confusional state—Methylprednisolone—atopic dermatitis	3.99e-05	0.000325	CcSEcCtD
Ziprasidone—Immune system disorder—Prednisone—atopic dermatitis	3.98e-05	0.000324	CcSEcCtD
Ziprasidone—Vertigo—Betamethasone—atopic dermatitis	3.96e-05	0.000322	CcSEcCtD
Ziprasidone—Vertigo—Dexamethasone—atopic dermatitis	3.96e-05	0.000322	CcSEcCtD
Ziprasidone—Syncope—Dexamethasone—atopic dermatitis	3.95e-05	0.000322	CcSEcCtD
Ziprasidone—Syncope—Betamethasone—atopic dermatitis	3.95e-05	0.000322	CcSEcCtD
Ziprasidone—Arrhythmia—Prednisone—atopic dermatitis	3.94e-05	0.000321	CcSEcCtD
Ziprasidone—Infection—Triamcinolone—atopic dermatitis	3.94e-05	0.000321	CcSEcCtD
Ziprasidone—Hypotension—Hydrocortisone—atopic dermatitis	3.93e-05	0.00032	CcSEcCtD
Ziprasidone—Infection—Methylprednisolone—atopic dermatitis	3.93e-05	0.00032	CcSEcCtD
Ziprasidone—Shock—Triamcinolone—atopic dermatitis	3.9e-05	0.000318	CcSEcCtD
Ziprasidone—Insomnia—Prednisolone—atopic dermatitis	3.9e-05	0.000317	CcSEcCtD
Ziprasidone—Alopecia—Prednisone—atopic dermatitis	3.89e-05	0.000317	CcSEcCtD
Ziprasidone—Shock—Methylprednisolone—atopic dermatitis	3.89e-05	0.000317	CcSEcCtD
Ziprasidone—Nervous system disorder—Methylprednisolone—atopic dermatitis	3.88e-05	0.000316	CcSEcCtD
Ziprasidone—Loss of consciousness—Dexamethasone—atopic dermatitis	3.87e-05	0.000315	CcSEcCtD
Ziprasidone—Loss of consciousness—Betamethasone—atopic dermatitis	3.87e-05	0.000315	CcSEcCtD
Ziprasidone—Paraesthesia—Prednisolone—atopic dermatitis	3.87e-05	0.000315	CcSEcCtD
Ziprasidone—Tachycardia—Triamcinolone—atopic dermatitis	3.87e-05	0.000315	CcSEcCtD
Ziprasidone—Mental disorder—Prednisone—atopic dermatitis	3.86e-05	0.000315	CcSEcCtD
Ziprasidone—Tachycardia—Methylprednisolone—atopic dermatitis	3.86e-05	0.000314	CcSEcCtD
Ziprasidone—Skin disorder—Methylprednisolone—atopic dermatitis	3.84e-05	0.000313	CcSEcCtD
Ziprasidone—Malnutrition—Prednisone—atopic dermatitis	3.84e-05	0.000313	CcSEcCtD
Ziprasidone—Erythema—Prednisone—atopic dermatitis	3.84e-05	0.000313	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	3.83e-05	0.000312	CcSEcCtD
Ziprasidone—Hyperhidrosis—Triamcinolone—atopic dermatitis	3.83e-05	0.000312	CcSEcCtD
Ziprasidone—Hyperhidrosis—Methylprednisolone—atopic dermatitis	3.82e-05	0.000311	CcSEcCtD
Ziprasidone—Insomnia—Hydrocortisone—atopic dermatitis	3.81e-05	0.00031	CcSEcCtD
Ziprasidone—Hypertension—Dexamethasone—atopic dermatitis	3.8e-05	0.00031	CcSEcCtD
Ziprasidone—Hypertension—Betamethasone—atopic dermatitis	3.8e-05	0.00031	CcSEcCtD
Ziprasidone—Paraesthesia—Hydrocortisone—atopic dermatitis	3.78e-05	0.000308	CcSEcCtD
Ziprasidone—Myalgia—Betamethasone—atopic dermatitis	3.75e-05	0.000306	CcSEcCtD
Ziprasidone—Myalgia—Dexamethasone—atopic dermatitis	3.75e-05	0.000306	CcSEcCtD
Ziprasidone—Anxiety—Dexamethasone—atopic dermatitis	3.74e-05	0.000304	CcSEcCtD
Ziprasidone—Anxiety—Betamethasone—atopic dermatitis	3.74e-05	0.000304	CcSEcCtD
Ziprasidone—Dyspepsia—Hydrocortisone—atopic dermatitis	3.7e-05	0.000302	CcSEcCtD
Ziprasidone—Hypotension—Methylprednisolone—atopic dermatitis	3.69e-05	0.000301	CcSEcCtD
Ziprasidone—Decreased appetite—Hydrocortisone—atopic dermatitis	3.66e-05	0.000298	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	3.63e-05	0.000296	CcSEcCtD
Ziprasidone—Fatigue—Hydrocortisone—atopic dermatitis	3.63e-05	0.000296	CcSEcCtD
Ziprasidone—Vision blurred—Prednisone—atopic dermatitis	3.61e-05	0.000295	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	3.61e-05	0.000294	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	3.6e-05	0.000293	CcSEcCtD
Ziprasidone—Insomnia—Triamcinolone—atopic dermatitis	3.58e-05	0.000292	CcSEcCtD
Ziprasidone—Insomnia—Methylprednisolone—atopic dermatitis	3.58e-05	0.000291	CcSEcCtD
Ziprasidone—Infection—Betamethasone—atopic dermatitis	3.57e-05	0.000291	CcSEcCtD
Ziprasidone—Infection—Dexamethasone—atopic dermatitis	3.57e-05	0.000291	CcSEcCtD
Ziprasidone—Paraesthesia—Triamcinolone—atopic dermatitis	3.56e-05	0.00029	CcSEcCtD
Ziprasidone—Feeling abnormal—Prednisolone—atopic dermatitis	3.55e-05	0.000289	CcSEcCtD
Ziprasidone—Paraesthesia—Methylprednisolone—atopic dermatitis	3.55e-05	0.000289	CcSEcCtD
Ziprasidone—Anaemia—Prednisone—atopic dermatitis	3.55e-05	0.000289	CcSEcCtD
Ziprasidone—Shock—Dexamethasone—atopic dermatitis	3.54e-05	0.000288	CcSEcCtD
Ziprasidone—Shock—Betamethasone—atopic dermatitis	3.54e-05	0.000288	CcSEcCtD
Ziprasidone—Dyspnoea—Triamcinolone—atopic dermatitis	3.53e-05	0.000288	CcSEcCtD
Ziprasidone—Nervous system disorder—Dexamethasone—atopic dermatitis	3.53e-05	0.000287	CcSEcCtD
Ziprasidone—Nervous system disorder—Betamethasone—atopic dermatitis	3.53e-05	0.000287	CcSEcCtD
Ziprasidone—Agitation—Prednisone—atopic dermatitis	3.52e-05	0.000287	CcSEcCtD
Ziprasidone—Thrombocytopenia—Dexamethasone—atopic dermatitis	3.52e-05	0.000287	CcSEcCtD
Ziprasidone—Thrombocytopenia—Betamethasone—atopic dermatitis	3.52e-05	0.000287	CcSEcCtD
Ziprasidone—Tachycardia—Betamethasone—atopic dermatitis	3.51e-05	0.000286	CcSEcCtD
Ziprasidone—Tachycardia—Dexamethasone—atopic dermatitis	3.51e-05	0.000286	CcSEcCtD
Ziprasidone—Angioedema—Prednisone—atopic dermatitis	3.5e-05	0.000286	CcSEcCtD
Ziprasidone—Dyspepsia—Triamcinolone—atopic dermatitis	3.49e-05	0.000284	CcSEcCtD
Ziprasidone—Dyspepsia—Methylprednisolone—atopic dermatitis	3.48e-05	0.000284	CcSEcCtD
Ziprasidone—Hyperhidrosis—Betamethasone—atopic dermatitis	3.48e-05	0.000283	CcSEcCtD
Ziprasidone—Hyperhidrosis—Dexamethasone—atopic dermatitis	3.48e-05	0.000283	CcSEcCtD
Ziprasidone—Feeling abnormal—Hydrocortisone—atopic dermatitis	3.47e-05	0.000283	CcSEcCtD
Ziprasidone—Vertigo—Prednisone—atopic dermatitis	3.45e-05	0.000281	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	3.44e-05	0.00028	CcSEcCtD
Ziprasidone—Syncope—Prednisone—atopic dermatitis	3.44e-05	0.00028	CcSEcCtD
Ziprasidone—Anorexia—Dexamethasone—atopic dermatitis	3.43e-05	0.000279	CcSEcCtD
Ziprasidone—Anorexia—Betamethasone—atopic dermatitis	3.43e-05	0.000279	CcSEcCtD
Ziprasidone—Urticaria—Prednisolone—atopic dermatitis	3.42e-05	0.000279	CcSEcCtD
Ziprasidone—Fatigue—Triamcinolone—atopic dermatitis	3.42e-05	0.000278	CcSEcCtD
Ziprasidone—Fatigue—Methylprednisolone—atopic dermatitis	3.41e-05	0.000278	CcSEcCtD
Ziprasidone—Loss of consciousness—Prednisone—atopic dermatitis	3.37e-05	0.000275	CcSEcCtD
Ziprasidone—Hypotension—Dexamethasone—atopic dermatitis	3.36e-05	0.000274	CcSEcCtD
Ziprasidone—Hypotension—Betamethasone—atopic dermatitis	3.36e-05	0.000274	CcSEcCtD
Ziprasidone—Urticaria—Hydrocortisone—atopic dermatitis	3.34e-05	0.000272	CcSEcCtD
Ziprasidone—Abdominal pain—Hydrocortisone—atopic dermatitis	3.33e-05	0.000271	CcSEcCtD
Ziprasidone—Body temperature increased—Hydrocortisone—atopic dermatitis	3.33e-05	0.000271	CcSEcCtD
Ziprasidone—Hypertension—Prednisone—atopic dermatitis	3.31e-05	0.00027	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	3.28e-05	0.000267	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	3.28e-05	0.000267	CcSEcCtD
Ziprasidone—Myalgia—Prednisone—atopic dermatitis	3.27e-05	0.000266	CcSEcCtD
Ziprasidone—Arthralgia—Prednisone—atopic dermatitis	3.27e-05	0.000266	CcSEcCtD
Ziprasidone—Feeling abnormal—Triamcinolone—atopic dermatitis	3.26e-05	0.000266	CcSEcCtD
Ziprasidone—Feeling abnormal—Methylprednisolone—atopic dermatitis	3.26e-05	0.000265	CcSEcCtD
Ziprasidone—Anxiety—Prednisone—atopic dermatitis	3.25e-05	0.000265	CcSEcCtD
Ziprasidone—Insomnia—Dexamethasone—atopic dermatitis	3.25e-05	0.000265	CcSEcCtD
Ziprasidone—Insomnia—Betamethasone—atopic dermatitis	3.25e-05	0.000265	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	3.24e-05	0.000264	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	3.23e-05	0.000263	CcSEcCtD
Ziprasidone—Paraesthesia—Dexamethasone—atopic dermatitis	3.23e-05	0.000263	CcSEcCtD
Ziprasidone—Paraesthesia—Betamethasone—atopic dermatitis	3.23e-05	0.000263	CcSEcCtD
Ziprasidone—Hypersensitivity—Prednisolone—atopic dermatitis	3.17e-05	0.000259	CcSEcCtD
Ziprasidone—Dyspepsia—Betamethasone—atopic dermatitis	3.16e-05	0.000258	CcSEcCtD
Ziprasidone—Dyspepsia—Dexamethasone—atopic dermatitis	3.16e-05	0.000258	CcSEcCtD
Ziprasidone—Urticaria—Triamcinolone—atopic dermatitis	3.15e-05	0.000256	CcSEcCtD
Ziprasidone—Urticaria—Methylprednisolone—atopic dermatitis	3.14e-05	0.000256	CcSEcCtD
Ziprasidone—Body temperature increased—Triamcinolone—atopic dermatitis	3.13e-05	0.000255	CcSEcCtD
Ziprasidone—Abdominal pain—Methylprednisolone—atopic dermatitis	3.12e-05	0.000255	CcSEcCtD
Ziprasidone—Decreased appetite—Dexamethasone—atopic dermatitis	3.12e-05	0.000255	CcSEcCtD
Ziprasidone—Decreased appetite—Betamethasone—atopic dermatitis	3.12e-05	0.000255	CcSEcCtD
Ziprasidone—Infection—Prednisone—atopic dermatitis	3.11e-05	0.000253	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Betamethasone—atopic dermatitis	3.1e-05	0.000253	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	3.1e-05	0.000253	CcSEcCtD
Ziprasidone—Hypersensitivity—Hydrocortisone—atopic dermatitis	3.1e-05	0.000253	CcSEcCtD
Ziprasidone—Fatigue—Betamethasone—atopic dermatitis	3.1e-05	0.000253	CcSEcCtD
Ziprasidone—Fatigue—Dexamethasone—atopic dermatitis	3.1e-05	0.000253	CcSEcCtD
Ziprasidone—Shock—Prednisone—atopic dermatitis	3.08e-05	0.000251	CcSEcCtD
Ziprasidone—Nervous system disorder—Prednisone—atopic dermatitis	3.07e-05	0.00025	CcSEcCtD
Ziprasidone—Tachycardia—Prednisone—atopic dermatitis	3.06e-05	0.000249	CcSEcCtD
Ziprasidone—Skin disorder—Prednisone—atopic dermatitis	3.04e-05	0.000248	CcSEcCtD
Ziprasidone—Hyperhidrosis—Prednisone—atopic dermatitis	3.03e-05	0.000247	CcSEcCtD
Ziprasidone—Asthenia—Hydrocortisone—atopic dermatitis	3.02e-05	0.000246	CcSEcCtD
Ziprasidone—Anorexia—Prednisone—atopic dermatitis	2.98e-05	0.000243	CcSEcCtD
Ziprasidone—Feeling abnormal—Dexamethasone—atopic dermatitis	2.96e-05	0.000241	CcSEcCtD
Ziprasidone—Feeling abnormal—Betamethasone—atopic dermatitis	2.96e-05	0.000241	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Betamethasone—atopic dermatitis	2.94e-05	0.00024	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Dexamethasone—atopic dermatitis	2.94e-05	0.00024	CcSEcCtD
Ziprasidone—Hypersensitivity—Triamcinolone—atopic dermatitis	2.92e-05	0.000238	CcSEcCtD
Ziprasidone—Hypersensitivity—Methylprednisolone—atopic dermatitis	2.91e-05	0.000237	CcSEcCtD
Ziprasidone—Diarrhoea—Hydrocortisone—atopic dermatitis	2.88e-05	0.000235	CcSEcCtD
Ziprasidone—Urticaria—Betamethasone—atopic dermatitis	2.86e-05	0.000233	CcSEcCtD
Ziprasidone—Urticaria—Dexamethasone—atopic dermatitis	2.86e-05	0.000233	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Prednisone—atopic dermatitis	2.85e-05	0.000232	CcSEcCtD
Ziprasidone—Dizziness—Prednisolone—atopic dermatitis	2.85e-05	0.000232	CcSEcCtD
Ziprasidone—Asthenia—Triamcinolone—atopic dermatitis	2.84e-05	0.000232	CcSEcCtD
Ziprasidone—Abdominal pain—Betamethasone—atopic dermatitis	2.84e-05	0.000232	CcSEcCtD
Ziprasidone—Body temperature increased—Betamethasone—atopic dermatitis	2.84e-05	0.000232	CcSEcCtD
Ziprasidone—Abdominal pain—Dexamethasone—atopic dermatitis	2.84e-05	0.000232	CcSEcCtD
Ziprasidone—Body temperature increased—Dexamethasone—atopic dermatitis	2.84e-05	0.000232	CcSEcCtD
Ziprasidone—Asthenia—Methylprednisolone—atopic dermatitis	2.84e-05	0.000231	CcSEcCtD
Ziprasidone—Insomnia—Prednisone—atopic dermatitis	2.83e-05	0.000231	CcSEcCtD
Ziprasidone—Paraesthesia—Prednisone—atopic dermatitis	2.81e-05	0.000229	CcSEcCtD
Ziprasidone—Dizziness—Hydrocortisone—atopic dermatitis	2.78e-05	0.000227	CcSEcCtD
Ziprasidone—Dyspepsia—Prednisone—atopic dermatitis	2.76e-05	0.000225	CcSEcCtD
Ziprasidone—Decreased appetite—Prednisone—atopic dermatitis	2.72e-05	0.000222	CcSEcCtD
Ziprasidone—Rash—Prednisolone—atopic dermatitis	2.72e-05	0.000221	CcSEcCtD
Ziprasidone—Dermatitis—Prednisolone—atopic dermatitis	2.71e-05	0.000221	CcSEcCtD
Ziprasidone—Diarrhoea—Methylprednisolone—atopic dermatitis	2.7e-05	0.00022	CcSEcCtD
Ziprasidone—Fatigue—Prednisone—atopic dermatitis	2.7e-05	0.00022	CcSEcCtD
Ziprasidone—Headache—Prednisolone—atopic dermatitis	2.7e-05	0.00022	CcSEcCtD
Ziprasidone—Constipation—Prednisone—atopic dermatitis	2.68e-05	0.000218	CcSEcCtD
Ziprasidone—Vomiting—Hydrocortisone—atopic dermatitis	2.68e-05	0.000218	CcSEcCtD
Ziprasidone—Rash—Hydrocortisone—atopic dermatitis	2.65e-05	0.000216	CcSEcCtD
Ziprasidone—Dermatitis—Hydrocortisone—atopic dermatitis	2.65e-05	0.000216	CcSEcCtD
Ziprasidone—Headache—Hydrocortisone—atopic dermatitis	2.64e-05	0.000215	CcSEcCtD
Ziprasidone—Dizziness—Triamcinolone—atopic dermatitis	2.62e-05	0.000213	CcSEcCtD
Ziprasidone—Dizziness—Methylprednisolone—atopic dermatitis	2.61e-05	0.000213	CcSEcCtD
Ziprasidone—Feeling abnormal—Prednisone—atopic dermatitis	2.58e-05	0.00021	CcSEcCtD
Ziprasidone—Asthenia—Betamethasone—atopic dermatitis	2.58e-05	0.00021	CcSEcCtD
Ziprasidone—Asthenia—Dexamethasone—atopic dermatitis	2.58e-05	0.00021	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Prednisone—atopic dermatitis	2.56e-05	0.000209	CcSEcCtD
Ziprasidone—Nausea—Prednisolone—atopic dermatitis	2.56e-05	0.000209	CcSEcCtD
Ziprasidone—Vomiting—Triamcinolone—atopic dermatitis	2.52e-05	0.000205	CcSEcCtD
Ziprasidone—Vomiting—Methylprednisolone—atopic dermatitis	2.51e-05	0.000205	CcSEcCtD
Ziprasidone—Nausea—Hydrocortisone—atopic dermatitis	2.5e-05	0.000204	CcSEcCtD
Ziprasidone—Rash—Triamcinolone—atopic dermatitis	2.5e-05	0.000204	CcSEcCtD
Ziprasidone—Dermatitis—Triamcinolone—atopic dermatitis	2.5e-05	0.000203	CcSEcCtD
Ziprasidone—Rash—Methylprednisolone—atopic dermatitis	2.49e-05	0.000203	CcSEcCtD
Ziprasidone—Dermatitis—Methylprednisolone—atopic dermatitis	2.49e-05	0.000203	CcSEcCtD
Ziprasidone—Urticaria—Prednisone—atopic dermatitis	2.49e-05	0.000203	CcSEcCtD
Ziprasidone—Headache—Triamcinolone—atopic dermatitis	2.48e-05	0.000202	CcSEcCtD
Ziprasidone—Headache—Methylprednisolone—atopic dermatitis	2.48e-05	0.000202	CcSEcCtD
Ziprasidone—Abdominal pain—Prednisone—atopic dermatitis	2.47e-05	0.000202	CcSEcCtD
Ziprasidone—Body temperature increased—Prednisone—atopic dermatitis	2.47e-05	0.000202	CcSEcCtD
Ziprasidone—Diarrhoea—Betamethasone—atopic dermatitis	2.46e-05	0.0002	CcSEcCtD
Ziprasidone—Diarrhoea—Dexamethasone—atopic dermatitis	2.46e-05	0.0002	CcSEcCtD
Ziprasidone—Dizziness—Dexamethasone—atopic dermatitis	2.38e-05	0.000194	CcSEcCtD
Ziprasidone—Dizziness—Betamethasone—atopic dermatitis	2.38e-05	0.000194	CcSEcCtD
Ziprasidone—Nausea—Triamcinolone—atopic dermatitis	2.35e-05	0.000192	CcSEcCtD
Ziprasidone—Nausea—Methylprednisolone—atopic dermatitis	2.35e-05	0.000191	CcSEcCtD
Ziprasidone—Hypersensitivity—Prednisone—atopic dermatitis	2.31e-05	0.000188	CcSEcCtD
Ziprasidone—Vomiting—Dexamethasone—atopic dermatitis	2.29e-05	0.000186	CcSEcCtD
Ziprasidone—Vomiting—Betamethasone—atopic dermatitis	2.29e-05	0.000186	CcSEcCtD
Ziprasidone—Rash—Betamethasone—atopic dermatitis	2.27e-05	0.000185	CcSEcCtD
Ziprasidone—Rash—Dexamethasone—atopic dermatitis	2.27e-05	0.000185	CcSEcCtD
Ziprasidone—Dermatitis—Betamethasone—atopic dermatitis	2.26e-05	0.000185	CcSEcCtD
Ziprasidone—Dermatitis—Dexamethasone—atopic dermatitis	2.26e-05	0.000185	CcSEcCtD
Ziprasidone—Headache—Betamethasone—atopic dermatitis	2.25e-05	0.000183	CcSEcCtD
Ziprasidone—Headache—Dexamethasone—atopic dermatitis	2.25e-05	0.000183	CcSEcCtD
Ziprasidone—Asthenia—Prednisone—atopic dermatitis	2.25e-05	0.000183	CcSEcCtD
Ziprasidone—Diarrhoea—Prednisone—atopic dermatitis	2.14e-05	0.000175	CcSEcCtD
Ziprasidone—Nausea—Dexamethasone—atopic dermatitis	2.14e-05	0.000174	CcSEcCtD
Ziprasidone—Nausea—Betamethasone—atopic dermatitis	2.14e-05	0.000174	CcSEcCtD
Ziprasidone—Dizziness—Prednisone—atopic dermatitis	2.07e-05	0.000169	CcSEcCtD
Ziprasidone—Vomiting—Prednisone—atopic dermatitis	1.99e-05	0.000162	CcSEcCtD
Ziprasidone—Rash—Prednisone—atopic dermatitis	1.97e-05	0.000161	CcSEcCtD
Ziprasidone—Dermatitis—Prednisone—atopic dermatitis	1.97e-05	0.000161	CcSEcCtD
Ziprasidone—Headache—Prednisone—atopic dermatitis	1.96e-05	0.00016	CcSEcCtD
Ziprasidone—Nausea—Prednisone—atopic dermatitis	1.86e-05	0.000152	CcSEcCtD
Ziprasidone—HTR6—Signaling Pathways—NFKBIA—atopic dermatitis	5.32e-06	9.71e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—NFKBIA—atopic dermatitis	5.32e-06	9.7e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—IL2—atopic dermatitis	5.31e-06	9.68e-05	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—PPARA—atopic dermatitis	5.31e-06	9.68e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—IL2—atopic dermatitis	5.29e-06	9.64e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling by GPCR—IL6—atopic dermatitis	5.29e-06	9.64e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	5.28e-06	9.63e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ADSL—atopic dermatitis	5.27e-06	9.61e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	5.26e-06	9.6e-05	CbGpPWpGaD
Ziprasidone—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	5.24e-06	9.55e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—IL2—atopic dermatitis	5.22e-06	9.51e-05	CbGpPWpGaD
Ziprasidone—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	5.21e-06	9.5e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	5.19e-06	9.47e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—GPCR downstream signaling—IL2—atopic dermatitis	5.19e-06	9.46e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	5.18e-06	9.44e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	5.17e-06	9.43e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	5.17e-06	9.42e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	5.16e-06	9.41e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—PPARA—atopic dermatitis	5.16e-06	9.4e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	5.15e-06	9.39e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	5.13e-06	9.36e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	5.13e-06	9.36e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—NFKBIA—atopic dermatitis	5.09e-06	9.28e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	5.08e-06	9.27e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	5.07e-06	9.24e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	5.07e-06	9.24e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	5.02e-06	9.16e-05	CbGpPWpGaD
Ziprasidone—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	5.01e-06	9.13e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	4.99e-06	9.1e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	4.99e-06	9.1e-05	CbGpPWpGaD
Ziprasidone—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	4.98e-06	9.08e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	4.95e-06	9.03e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	4.93e-06	8.99e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—CXCL8—atopic dermatitis	4.92e-06	8.97e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	4.91e-06	8.96e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—MAPK8—atopic dermatitis	4.89e-06	8.91e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	4.85e-06	8.83e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	4.82e-06	8.78e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	4.81e-06	8.77e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—NGF—atopic dermatitis	4.78e-06	8.71e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	4.77e-06	8.69e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	4.76e-06	8.67e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—NGF—atopic dermatitis	4.75e-06	8.67e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	4.73e-06	8.63e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	4.71e-06	8.59e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	4.71e-06	8.59e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—IL2—atopic dermatitis	4.7e-06	8.57e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling by GPCR—IL6—atopic dermatitis	4.68e-06	8.53e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	4.65e-06	8.48e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	4.63e-06	8.43e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	4.62e-06	8.43e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	4.6e-06	8.39e-05	CbGpPWpGaD
Ziprasidone—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	4.6e-06	8.39e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	4.58e-06	8.36e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—PPARA—atopic dermatitis	4.57e-06	8.32e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	4.55e-06	8.3e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	4.55e-06	8.29e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	4.53e-06	8.26e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CCL5—atopic dermatitis	4.53e-06	8.26e-05	CbGpPWpGaD
Ziprasidone—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	4.53e-06	8.25e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	4.52e-06	8.25e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	4.52e-06	8.24e-05	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.52e-06	8.23e-05	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.5e-06	8.21e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	4.5e-06	8.2e-05	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	4.49e-06	8.18e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	4.46e-06	8.13e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CCL5—atopic dermatitis	4.45e-06	8.11e-05	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	4.44e-06	8.1e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	4.43e-06	8.08e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	4.43e-06	8.08e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	4.43e-06	8.07e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	4.42e-06	8.06e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	4.4e-06	8.02e-05	CbGpPWpGaD
Ziprasidone—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	4.4e-06	8.01e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	4.38e-06	7.98e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	4.37e-06	7.96e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	4.33e-06	7.89e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—MAPK8—atopic dermatitis	4.33e-06	7.89e-05	CbGpPWpGaD
Ziprasidone—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	4.33e-06	7.89e-05	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	4.32e-06	7.87e-05	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	4.3e-06	7.84e-05	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	4.29e-06	7.82e-05	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	4.25e-06	7.74e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	4.24e-06	7.72e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—NGF—atopic dermatitis	4.2e-06	7.65e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PPARA—atopic dermatitis	4.19e-06	7.64e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	4.18e-06	7.62e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—NGF—atopic dermatitis	4.13e-06	7.53e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—NGF—atopic dermatitis	4.12e-06	7.51e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	4.12e-06	7.51e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	4.11e-06	7.49e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—NGF—atopic dermatitis	4.11e-06	7.49e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	4.1e-06	7.48e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—NGF—atopic dermatitis	4.09e-06	7.46e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	4.09e-06	7.45e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	4.08e-06	7.44e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CCR5—atopic dermatitis	4.08e-06	7.44e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	4.08e-06	7.43e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	4.06e-06	7.39e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—NGF—atopic dermatitis	4.05e-06	7.39e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	4.04e-06	7.37e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	4.04e-06	7.36e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	4.02e-06	7.34e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	4.02e-06	7.32e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CCR5—atopic dermatitis	4.01e-06	7.31e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	3.99e-06	7.28e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—IL2—atopic dermatitis	3.99e-06	7.28e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	3.98e-06	7.26e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	3.94e-06	7.19e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	3.94e-06	7.18e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	3.94e-06	7.17e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	3.93e-06	7.17e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	3.93e-06	7.16e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	3.92e-06	7.15e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—IL2—atopic dermatitis	3.92e-06	7.15e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	3.91e-06	7.12e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	3.89e-06	7.1e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	3.86e-06	7.03e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	3.85e-06	7.01e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PPARA—atopic dermatitis	3.84e-06	7e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	3.81e-06	6.95e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—CXCL8—atopic dermatitis	3.8e-06	6.92e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—CXCL8—atopic dermatitis	3.79e-06	6.91e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	3.77e-06	6.87e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	3.76e-06	6.85e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	3.75e-06	6.84e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	3.74e-06	6.82e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	3.69e-06	6.73e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	3.65e-06	6.66e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—CXCL8—atopic dermatitis	3.63e-06	6.62e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IL2—atopic dermatitis	3.63e-06	6.62e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IL2—atopic dermatitis	3.62e-06	6.61e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling by GPCR—IL6—atopic dermatitis	3.61e-06	6.58e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling by GPCR—IL6—atopic dermatitis	3.61e-06	6.57e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IL2—atopic dermatitis	3.6e-06	6.56e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	3.58e-06	6.53e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	3.58e-06	6.53e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	3.57e-06	6.52e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL2—atopic dermatitis	3.53e-06	6.43e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	3.51e-06	6.4e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL2—atopic dermatitis	3.47e-06	6.33e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	3.46e-06	6.31e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling by GPCR—IL6—atopic dermatitis	3.45e-06	6.29e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	3.43e-06	6.25e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL2—atopic dermatitis	3.42e-06	6.24e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	3.41e-06	6.21e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	3.4e-06	6.21e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	3.4e-06	6.19e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	3.39e-06	6.17e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	3.38e-06	6.15e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	3.34e-06	6.09e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—MAPK8—atopic dermatitis	3.34e-06	6.09e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—MAPK8—atopic dermatitis	3.34e-06	6.08e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	3.33e-06	6.08e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	3.31e-06	6.04e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL2—atopic dermatitis	3.28e-06	5.98e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	3.27e-06	5.96e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	3.26e-06	5.95e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	3.25e-06	5.92e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	3.23e-06	5.88e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—MAPK8—atopic dermatitis	3.19e-06	5.82e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	3.15e-06	5.74e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL2—atopic dermatitis	3.12e-06	5.69e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—IL6—atopic dermatitis	3.12e-06	5.69e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—IL6—atopic dermatitis	3.11e-06	5.67e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	3.1e-06	5.65e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL2—atopic dermatitis	3.08e-06	5.62e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—IL6—atopic dermatitis	3.07e-06	5.59e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	3.02e-06	5.5e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	2.91e-06	5.31e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	2.88e-06	5.24e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	2.84e-06	5.17e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	2.81e-06	5.12e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	2.8e-06	5.1e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	2.78e-06	5.07e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	2.77e-06	5.05e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—IL6—atopic dermatitis	2.76e-06	5.04e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PPARA—atopic dermatitis	2.73e-06	4.98e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	2.72e-06	4.96e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL2—atopic dermatitis	2.69e-06	4.9e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	2.68e-06	4.88e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	2.67e-06	4.87e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL2—atopic dermatitis	2.67e-06	4.87e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	2.66e-06	4.85e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	2.6e-06	4.74e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	2.59e-06	4.71e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	2.56e-06	4.67e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	2.56e-06	4.66e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	2.55e-06	4.64e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	2.47e-06	4.51e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	2.47e-06	4.5e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	2.46e-06	4.48e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	2.43e-06	4.43e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	2.42e-06	4.42e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	2.42e-06	4.4e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	2.41e-06	4.39e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	2.39e-06	4.36e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	2.38e-06	4.35e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	2.38e-06	4.33e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL2—atopic dermatitis	2.36e-06	4.3e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	2.35e-06	4.29e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—IL6—atopic dermatitis	2.35e-06	4.28e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL2—atopic dermatitis	2.32e-06	4.23e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL2—atopic dermatitis	2.32e-06	4.22e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PPARA—atopic dermatitis	2.31e-06	4.22e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	2.31e-06	4.21e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL2—atopic dermatitis	2.31e-06	4.21e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—IL6—atopic dermatitis	2.3e-06	4.2e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL2—atopic dermatitis	2.3e-06	4.19e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	2.3e-06	4.19e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	2.29e-06	4.17e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL2—atopic dermatitis	2.28e-06	4.15e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	2.27e-06	4.14e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	2.27e-06	4.13e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	2.26e-06	4.12e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	2.21e-06	4.03e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	2.17e-06	3.96e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	2.14e-06	3.89e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IL6—atopic dermatitis	2.13e-06	3.89e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	2.13e-06	3.89e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IL6—atopic dermatitis	2.13e-06	3.88e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	2.12e-06	3.87e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	2.12e-06	3.86e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IL6—atopic dermatitis	2.12e-06	3.86e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	2.11e-06	3.85e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	2.1e-06	3.83e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	2.1e-06	3.82e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	2.09e-06	3.81e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL6—atopic dermatitis	2.07e-06	3.78e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL6—atopic dermatitis	2.04e-06	3.72e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL6—atopic dermatitis	2.01e-06	3.67e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	1.94e-06	3.54e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL6—atopic dermatitis	1.93e-06	3.51e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL6—atopic dermatitis	1.84e-06	3.35e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL6—atopic dermatitis	1.81e-06	3.3e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.78e-06	3.25e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	1.64e-06	2.98e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL6—atopic dermatitis	1.58e-06	2.88e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL6—atopic dermatitis	1.57e-06	2.86e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	1.53e-06	2.79e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	1.5e-06	2.74e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL6—atopic dermatitis	1.39e-06	2.53e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL6—atopic dermatitis	1.36e-06	2.49e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL6—atopic dermatitis	1.36e-06	2.48e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL6—atopic dermatitis	1.36e-06	2.47e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL6—atopic dermatitis	1.35e-06	2.47e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL6—atopic dermatitis	1.34e-06	2.44e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	1.34e-06	2.43e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	1.24e-06	2.26e-05	CbGpPWpGaD
